Compare $CNSY vs $PTN | Chartloom

Compare

$CNSY vs $PTN

Plus Therapeutics Inc · Palatin Technologies Inc

CNSY

Plus Therapeutics Inc

PTN

Palatin Technologies Inc

Compare $CNSY vs $PTN

Comparing Plus Therapeutics Inc and Palatin Technologies Inc

CNSYPlus Therapeutics Inc

PTNPalatin Technologies Inc

CNSYPlus Therapeutics Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.12x

Rev growth (TTM)

—

YTD performance

-45.2%

52W performance

-45.2%

FCF yield

-267.6%

PTNPalatin Technologies Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

3581.2%

YTD performance

-46.4%

52W performance

19.6%

FCF yield

-88.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CNSY

PTN

Detailed metrics comparison

CNSY

Plus Therapeutics Inc

PTN

Palatin Technologies Inc

Market Cap

CNSY$13M

PTN$15M

Enterprise Value

CNSY$11M

PTN$8M

Price

CNSY$1.93

PTN$8.60

P/E Ratio

CNSYN/A

PTNN/A

P/S Ratio

CNSY3.16x

PTN1.16x

EV/Sales

CNSY2.60x

PTN0.59x

EV/EBITDA

CNSY0.00x

PTN0.18x

P/B Ratio

CNSY2.22x

PTN1.57x

P/FCF Ratio

CNSYN/A

PTNN/A

EV/FCF

CNSY-0.31x

PTN-0.58x

PEG Ratio

CNSYN/A

PTNN/A

Forward P/E (NTM)

CNSYN/A

PTNN/A

Forward P/S (NTM)

CNSY1.12x

PTNN/A

Revenue (TTM)

CNSY$4M

PTN$13M

Revenue Growth (YoY)

CNSYN/A

PTN3581.2%

Forward Rev Growth

CNSY216.6%

PTN-58.6%

Gross Margin (TTM)

CNSY0.0%

PTN97.8%

Operating Margin (TTM)

CNSY0.0%

PTN0.0%

EBITDA Margin (TTM)

CNSY-612.0%

PTN-65.3%

Net Margin (TTM)

CNSY-620.7%

PTN-63.5%

FCF Margin (TTM)

CNSY-845.3%

PTN-103.0%

Net Income (TTM)

CNSY$-26M

PTN$-8M

FCF (TTM)

CNSY$-36M

PTN$-14M

EPS (TTM)

CNSY-$3.78

PTN-$2.14

ROE (TTM)

CNSY-39417.0%

PTN-5370.0%

ROA (TTM)

CNSY-15136.0%

PTN-5808.0%

ROIC (TTM)

CNSY-37414.0%

PTN-5370.0%

Cash

CNSY$2M

PTN$7M

Debt

CNSY$0

PTN$0

Net Cash/Debt

CNSY$2M

PTN$7M

Current Ratio (TTM)

CNSY1.37x

PTN5.04x

Quick Ratio (TTM)

CNSY1.26x

PTN4.93x

Debt/Equity (TTM)

CNSY0.19x

PTN2.00x

Debt/Assets (TTM)

CNSY0.0%

PTN0.0%

Interest Coverage (TTM)

CNSYN/A

PTNN/A

Net Debt/EBITDA (TTM)

CNSY0.00x

PTN0.00x

Beta

CNSY2.21

PTN0.84

52W Performance

CNSY-45.2%

PTN19.6%

YTD Performance

CNSY-45.2%

PTN-46.4%

% from 52W High

CNSY-53.6%

PTN-72.3%

% from 52W Low

CNSY30.0%

PTN53.3%

Asset Turnover (TTM)

CNSY0.24x

PTN0.97x

FCF Yield (TTM)

CNSY-267.6%

PTN-88.7%

Earnings Yield (TTM)

CNSY-196.5%

PTN-54.7%

Dividend Yield (TTM)

CNSYN/A

PTNN/A

Rule of 40

CNSY-845.3

PTN3,478.2

EV/GP/RG

CNSYN/A

PTNN/A

Ticker research

View CNSY research View PTN research

Metric	CNSY Plus Therapeutics Inc	PTN Palatin Technologies Inc
Market & Valuation
Market Cap	$13M	$15M
Enterprise Value	$11M	$8M
Price	$1.93	$8.60
P/E Ratio	N/A	N/A
P/S Ratio	3.16x	1.16x
EV/Sales	2.60x	0.59x
EV/EBITDA	0.00x	0.18x
P/B Ratio	2.22x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.31x	-0.58x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.12x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$13M
Revenue Growth (YoY)	N/A	3581.2%
Forward Rev Growth	216.6%	-58.6%
Profitability
Gross Margin (TTM)	0.0%	97.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-612.0%	-65.3%
Net Margin (TTM)	-620.7%	-63.5%
FCF Margin (TTM)	-845.3%	-103.0%
Net Income (TTM)	$-26M	$-8M
FCF (TTM)	$-36M	$-14M
EPS (TTM)	-$3.78	-$2.14
ROE (TTM)	-39417.0%	-5370.0%
ROA (TTM)	-15136.0%	-5808.0%
ROIC (TTM)	-37414.0%	-5370.0%
Financial Health
Cash	$2M	$7M
Debt	$0	$0
Net Cash/Debt	$2M	$7M
Current Ratio (TTM)	1.37x	5.04x
Quick Ratio (TTM)	1.26x	4.93x
Debt/Equity (TTM)	0.19x	2.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.21	0.84
52W Performance	-45.2%	19.6%
YTD Performance	-45.2%	-46.4%
% from 52W High	-53.6%	-72.3%
% from 52W Low	30.0%	53.3%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	0.97x
FCF Yield (TTM)	-267.6%	-88.7%
Earnings Yield (TTM)	-196.5%	-54.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-845.3	3,478.2
EV/GP/RG	N/A	N/A
Ticker research	View CNSY research	View PTN research

Valuation

P/S Ratio

PTN

1.16x

CNSY

3.16x

EV/FCF

PTN

-0.58x

CNSY

-0.31x

Growth & revenue

Revenue Growth TTM

PTN

3581.2%

Forward Revenue Growth

CNSY

216.6%

PTN

-58.6%

Profitability & performance

Gross Margin

PTN

97.8%

CNSY

0.0%

ROE

PTN

-5370.0%

CNSY

-39417.0%

FCF Yield %

PTN

-88.7%

CNSY

-267.6%

52-Week Performance

PTN

19.6%

CNSY

-45.2%

Detailed metrics comparison

CNSY

Plus Therapeutics Inc

PTN

Palatin Technologies Inc

Market Cap

CNSY$13M

PTN$15M

Enterprise Value

CNSY$11M

PTN$8M

Price

CNSY$1.93

PTN$8.60

P/E Ratio

CNSYN/A

PTNN/A

P/S Ratio

CNSY3.16x

PTN1.16x

EV/Sales

CNSY2.60x

PTN0.59x

EV/EBITDA

CNSY0.00x

PTN0.18x

P/B Ratio

CNSY2.22x

PTN1.57x

P/FCF Ratio

CNSYN/A

PTNN/A

EV/FCF

CNSY-0.31x

PTN-0.58x

PEG Ratio

CNSYN/A

PTNN/A

Forward P/E (NTM)

CNSYN/A

PTNN/A

Forward P/S (NTM)

CNSY1.12x

PTNN/A

Revenue (TTM)

CNSY$4M

PTN$13M

Revenue Growth (YoY)

CNSYN/A

PTN3581.2%

Forward Rev Growth

CNSY216.6%

PTN-58.6%

Gross Margin (TTM)

CNSY0.0%

PTN97.8%

Operating Margin (TTM)

CNSY0.0%

PTN0.0%

EBITDA Margin (TTM)

CNSY-612.0%

PTN-65.3%

Net Margin (TTM)

CNSY-620.7%

PTN-63.5%

FCF Margin (TTM)

CNSY-845.3%

PTN-103.0%

Net Income (TTM)

CNSY$-26M

PTN$-8M

FCF (TTM)

CNSY$-36M

PTN$-14M

EPS (TTM)

CNSY-$3.78

PTN-$2.14

ROE (TTM)

CNSY-39417.0%

PTN-5370.0%

ROA (TTM)

CNSY-15136.0%

PTN-5808.0%

ROIC (TTM)

CNSY-37414.0%

PTN-5370.0%

Cash

CNSY$2M

PTN$7M

Debt

CNSY$0

PTN$0

Net Cash/Debt

CNSY$2M

PTN$7M

Current Ratio (TTM)

CNSY1.37x

PTN5.04x

Quick Ratio (TTM)

CNSY1.26x

PTN4.93x

Debt/Equity (TTM)

CNSY0.19x

PTN2.00x

Debt/Assets (TTM)

CNSY0.0%

PTN0.0%

Interest Coverage (TTM)

CNSYN/A

PTNN/A

Net Debt/EBITDA (TTM)

CNSY0.00x

PTN0.00x

Beta

CNSY2.21

PTN0.84

52W Performance

CNSY-45.2%

PTN19.6%

YTD Performance

CNSY-45.2%

PTN-46.4%

% from 52W High

CNSY-53.6%

PTN-72.3%

% from 52W Low

CNSY30.0%

PTN53.3%

Asset Turnover (TTM)

CNSY0.24x

PTN0.97x

FCF Yield (TTM)

CNSY-267.6%

PTN-88.7%

Earnings Yield (TTM)

CNSY-196.5%

PTN-54.7%

Dividend Yield (TTM)

CNSYN/A

PTNN/A

Rule of 40

CNSY-845.3

PTN3,478.2

EV/GP/RG

CNSYN/A

PTNN/A

Ticker research

View CNSY research View PTN research

Metric	CNSY Plus Therapeutics Inc	PTN Palatin Technologies Inc
Market & Valuation
Market Cap	$13M	$15M
Enterprise Value	$11M	$8M
Price	$1.93	$8.60
P/E Ratio	N/A	N/A
P/S Ratio	3.16x	1.16x
EV/Sales	2.60x	0.59x
EV/EBITDA	0.00x	0.18x
P/B Ratio	2.22x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.31x	-0.58x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.12x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$13M
Revenue Growth (YoY)	N/A	3581.2%
Forward Rev Growth	216.6%	-58.6%
Profitability
Gross Margin (TTM)	0.0%	97.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-612.0%	-65.3%
Net Margin (TTM)	-620.7%	-63.5%
FCF Margin (TTM)	-845.3%	-103.0%
Net Income (TTM)	$-26M	$-8M
FCF (TTM)	$-36M	$-14M
EPS (TTM)	-$3.78	-$2.14
ROE (TTM)	-39417.0%	-5370.0%
ROA (TTM)	-15136.0%	-5808.0%
ROIC (TTM)	-37414.0%	-5370.0%
Financial Health
Cash	$2M	$7M
Debt	$0	$0
Net Cash/Debt	$2M	$7M
Current Ratio (TTM)	1.37x	5.04x
Quick Ratio (TTM)	1.26x	4.93x
Debt/Equity (TTM)	0.19x	2.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.21	0.84
52W Performance	-45.2%	19.6%
YTD Performance	-45.2%	-46.4%
% from 52W High	-53.6%	-72.3%
% from 52W Low	30.0%	53.3%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	0.97x
FCF Yield (TTM)	-267.6%	-88.7%
Earnings Yield (TTM)	-196.5%	-54.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-845.3	3,478.2
EV/GP/RG	N/A	N/A
Ticker research	View CNSY research	View PTN research